Log in

Relevant bibliographies by topics / An agonist of beta-blockers / Books

To see the other types of publications on this topic, follow the link: An agonist of beta-blockers.

Books on the topic 'An agonist of beta-blockers'

Author: Grafiati

Published: 7 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'An agonist of beta-blockers.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Cleophas, Ton J. M. Beta-blockers in hypertension and angina pectoris: Different compounds, differenct strategies. Kluwer Academic Publishers, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Richard, Beasley, and Pearce Neil, eds. The Role of beta receptor agonist therapy in asthma mortality. CRC Press, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Elliott, Christopher Trevor. Detection of residues of the beta-agonist clenbuterol in medicated farm animals. The Author], 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zug, Naser Abd-Asalam. Studies of the bronchodilator action of the long acting [beta]2-agonist (salmeterol) in normal human subjects. University of Manchester, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Momoka, Endo, and Matsumoto Nanami, eds. Beta blockers: New research. Nova Science Publishers, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Prichard, Brian N. C. 1932-, ed. Beta-blockers in clinical practice. Churchill Livingstone, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Cruickshank, J. M. Beta-blockers in clinical practice. Churchill Livingstone, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

1948-, Deedwania Prakash C., ed. Beta-blockers and cardiac arrhythmias. M. Dekker, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

1936-, Saunders Kenneth B., European Society for Clinical Respiratory Physiology., and European Society of Pneumology, eds. Formoterol: A long-acting B2-agonist for the management of asthma : an international symposium held during the joint meeting of SEP and SEPCR, London, 1990. Hogrefe & Huber, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fritz, Bärbel. Zur Wirkung des [beta]2-Sympathomimetikums [Beta-Sympathomimetikums] Clenbuterol und des [beta]-Blockers [Beta-Blockers] Carazolol auf das Myometrium der Ratte unter Östrogeneinfluss. [s.n.], 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Cleophas, Ton J. M. Beta-Blockers in Hypertension and Angina Pectoris. Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0129-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Radlspeck, Anton. Pharmakokinetik und Pharmakodynamik des Beta-Blockers Metoprolol. [s.n.], 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

1946-, Barnes Peter J., Matthys Heinrich, and European Society of Pneumology. Congress, eds. Formoterol--a new-generation [beta] 2-agonist: An international symposium held during the 8th Congress of the European Society of Pneumology, Freiburg, Federal Republic of Germany, September 1989. Hogrefe & Huber, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Dorr, Walter. Der therapeutische Einsatz des [beta]-Blockers [Beta-Blockers] Carazolol und des Endomorphinantagonisten Naltrexon bei der Nachgeburtsverhaltung beim Rind. [s.n.], 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Romain, Pauwels, and O'Byrne Paul M. 1951-, eds. Beta₂-agonists in asthma treatment. Dekker, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Cerney, Igor. How to take your medicine: Beta blocker drugs. Food and Drug Administration, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Skinner, Jonathan. Technology adoption from hybrid corn to beta blockers. National Bureau of Economic Research, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Skinner, Jonathan. Technology adoption from hybrid corn to beta blockers. National Bureau of Economic Research, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

J, Davies Robert, and European Society of Pneumology. Congress, eds. Formoterol: Clinical profile of a new long-acting inhaled [beta]2-agonist : an international symposium held during the VIIth Congress of the European Society of Pneumology (SEP), Budapest, 1988. Hogrefe & Huber, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

Dr, Johnson Malcolm, Small Roger, British Pharmacological Society Meeting, and Glaxo Group Research Limited, eds. [Beta]-adrenoceptor agonists and the airways: Held as satellite meeting to the British Pharmacological Society Meeting, School of Biological Sciences, University of Manchester, 12-15 April 1994. Royal Society of Medicine Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

P, Hanrahan J., and Commission of the European Communities. Coordination of Agricultural Research., eds. Beta-agonists and their effects on animal growth and carcass quality: A seminar in the CEC Programme of Coordination of Research in Animal Husbandry, held in Brussels, 19-20 May 1987. Elsevier Applied Science, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Grassitelli, A. Impiego di beta agonisti in alimentazione animale. Istituto superiore di sanità, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Friedrich, Kummer, and Vienna Asthma Forum (6th : 1996), eds. Treatment of asthma: The long-acting beta-2-agonists. Springer-Verlag, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Rotheim, Philip. Receptor agonists and blockers: Products, applications, medical sales, and new developments. Business Communications Co., 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

D, Strosberg A., ed. The B₃-adrenoreceptor. Taylor & Francis, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Akhlaghi, Shirin. The metabolic effects of beta-agonists and antagonists: Focus on beta-1 selectivity. University of Birmingham, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

1944-, Costello J. F., and Mann Ronald D. 1928-, eds. Beta agonists in the treatment of asthma: The proceedings. Parthenon Pub. Group, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Jonathan, Abrams, Pepine Carl J, and Thadani Udho, eds. Medical therapy of ischemic heart disease: Nitrates, beta blockers, and calcium antagonists. Little, Brown and Co., 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Kummer, Friedrich, ed. Treatment of Asthma: The long-acting beta-2-agonists. Springer Vienna, 1998. http://dx.doi.org/10.1007/978-3-7091-7513-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

1946-, Frishman William H., ed. Beta₃-adrenergic agonism: A new concept in human pharmacotherapy. Futura, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Gill, Hardyal Singh. Soft [beta]-adrenoceptor agonists for topical use in psoriasis. Aston University. Department of Pharmaceutical and Biological Sciences, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Parker, Philip M., and James N. Parker. Beta blockers: A medical dictionary, bibliography, and annotated research guide to Internet references. ICON Health Publications, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Weersink, Els J. M. The natural variability in asthma: Two therapeutic approaches. E. Weersink, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

J, Delic, and Great Britain. Health and Safety Executive., eds. Propranolol: Criteria document for an occupational exposure limit. HSE Books, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

A, Heidenreich Paul, and United States. Agency for Healthcare Research and Quality., eds. An evaluation of beta-blockers, calcium antagonists, nitrates, and alternative therapies for stable angina. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Heidenreich, Paul A. An evaluation of beta-blockers, calcium antagonists, nitrates, and alternative therapies for stable angina. U.S. Dept. of Health and Human Services, Agency for Healthcare Research and Quality, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

P, Hanrahan J., Commission of the European Communities., CEC Programme of Coordination of Research in Animal Husbandry., and Commission of the European Communities. Coordination of Agricultural Research., eds. Beta-agonists and their effects on animal growth and carcass quality. Elsevier Applied Science, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

1944-, Costello J. F., and Royal Society of Medicine (Great Britain). Respiratory Section., eds. Sympathomimetic enantiomers in the treatment of asthma: The proceedings of a meeting held by the Respiratory Section of the Royal Society of Medicine, London, October 1995. Parthenon Pub. Group, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

W, Berger, ed. Metabolic control in diabetes mellitus ; Beta adrenoceptor blocking drugs ; NMR analysis of cancer cells ; Immunoassay in the clinical laboratory ; Cyclosporine. Springer-Verlag, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

van, Zwieten P. A., and Royal Society of Medicine Services (Great Britain), eds. Vasodilatation and beta-blockade: A new standard in hypertension? : proceedings of a symposium sponsored by Rhône-Poulenc Rorer BV, held in Geneva on 11 February 1992. Royal Society of Medicine Services, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Beta-blockers in hypertension and angina pectoris: Different compounds, different strategies. Kluwer Academic Publishers, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

McCaffrey, Patricia Marian. Studies of agonist and partial agonist activity at the beta-adrenoceptor in man. 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Beasley, Richard, and Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Beasley, Richard, and Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Pearce, Neil, and Richard Beasley. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Beasley, Richard, and Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Beasley, Richard, and Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Beasley, Richard, and Neil E. Pearce. The Role of Beta Receptor Agonist Therapy in Asthma Mortality. Edited by Richard Beasley and Neil E. Pearce. CRC Press, 2020. http://dx.doi.org/10.1201/9780429281082.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Fayssoil, Abdallah, and Djillali Annane. Inotropic agents in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0036.

Full text

Abstract:

Inotropes are drugs commonly used in the intensive care unit. This class of agents includes a broad variety of molecules that improve cardiac index by increasing intracellular concentrations of cyclic AMP, or sensitivity to intracellular calcium, or by inhibiting the sodium/potassium pump. The main inotropic agents available are digoxin, catecholamines, and non-catecholergic drugs, e.g. phosphodiesterase inhibitors and levosimendan. In practice, dobutamine, a beta1 and beta2 agonist, is the inotrope of choice in patients with acute heart failure, or in patients with severe sepsis and evidence

APA, Harvard, Vancouver, ISO, and other styles

50

The 2006-2011 World Outlook for Non-Prescription Beta Agonist Cough and Cold Preparations. Icon Group International, Inc., 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!